Tag Archives: Market

ThreatSpike Red Disrupts Elite Cybersecurity Market with Revolutionary Offensive Cybersecurity Service for all Businesses

Industry-first fixed price managed offensive security service aims to close the cybersecurity gap, strengthen customers’ cyber defence posture, and reduce risk London, UK – [30th January 2023]: ThreatSpike, the straight-talking cybersecurity services company, today announced the launch of ThreatSpike Red, the industry’s first unlimited offensive cybersecurity service. ThreatSpike Red helps organisations of all sizes to… Read More »

Fishless fish burger comes to market

AS livestock industries push back against marketing claims being made by the makers of plant-based proteins, yet another new ‘no-meat meat’ product has hit the market. Dutch company Schouten, which has one of the world’s most extensive meat alternative ranges and sells into 50 countries, has launched a fishless fish burger. The company says fish… Read More »

Framo on a clear course: New investments of 15 million euros, market presence strengthened

Top meeting of Framo GmbH, Löbichau: Investor and main shareholder Majed Al-Askar announces high investments With 5 million euros in the current fiscal year 2021 and a further 10 million euros in 2022, the Saxon eTruck designers and retrofitters are once again committing to future markets Research, development and battery production to be significantly expanded… Read More »

5 things to know before the stock market opens Friday

Here are the most important news, trends and analysis that investors need to start their trading day: 1. Stock futures rose after light May jobs report Traders at the New York Stock Exchange. Source: NYSE U.S. President Joe Biden, left, wears a protective mask while speaking during a meeting with Senator Shelley Moore Capito, a… Read More »

Pfizer halts biosimilar programs in crowded China market, sells plant to WuXi Biologics

China only approved its first biosimilar drug in 2019, but the market is already looking too crowded for one Big Pharma company. Pfizer has halted its biosimilar programs in China and is selling a biologics facility there to Chinese CDMO giant WuXi Biologics, the company said in a statement Wednesday. The “difficult decision” came after a… Read More »